Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab
New England Journal of Medicine (2021) - Comments
doi: 10.1056/nejmoa2107934  issn: 0028-4793  issn: 1533-4406  pubmed: 34706189 

Anil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya, Diego R. Falci, Elias Sarkis, Joel Solis, Hanzhe Zheng, Nicola Scott, Andrea L. Cathcart, Christy M. Hebner, Jennifer Sager, Erik Mogalian, Craig Tipple, Amanda Peppercorn, Elizabeth Alexander, Phillip S. Pang, Almena Free, Cynthia Brinson